Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
April 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 |
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
Press releases published on March 14, 2025
Less Than One Month Until the 5th Annual Autism in Black Conference
EIN Presswire
·
March 14, 2025
WEST PALM BEACH , FL, UNITED STATES, March 14, 2025 /EINPresswire.com/ -- The countdown is on! The 5th Annual Autism in Black Conference is less than a month away, taking place April 11-13, 2025, at the Palm Beach Convention Center in West Palm Beach, FL …
Planet TV Studios Presents a Landmark Episode of New Frontiers, Showcasing 5 Leading Innovators – Airing March 15th on Bloomberg. The content in the episode is a Planet TV Studios Original & it is brought to you by & sponsored by Planet TV Studios
EIN Presswire
·
March 14, 2025
Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air Saturday, March 15th 2025 on Bloomberg Television. BOCA RATON, FL, UNITED STATES, March 14, 2025 / …
LeverX to Present Cutting-Edge Enterprise Solutions at eMerge Americas 2025
EIN Presswire
·
March 14, 2025
March 27-28, 2025 | Miami Beach Convention Center MIAMI, FL, UNITED STATES, March 14, 2025 /EINPresswire.com/ -- LeverX will participate in eMerge Americas 2025, a premier global technology conference and expo, taking place on March 27-28, 2025, in …
Cannabix Technologies announces Stock Option Grant and Director Resignation
GlobeNewswire
·
March 14, 2025
VANCOUVER, British Columbia, March 14, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports it is granting 3,375,000 incentive stock options to officers, directors and …
Federal Support for People with Asthma and Allergies at Risk
GlobeNewswire
·
March 14, 2025
Washington, DC, March 14, 2025 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) is deeply concerned about recent federal actions and congressional budget threats that could put millions of Americans with asthma and allergies at risk. …
Arch Biopartners Closes Non-Brokered Private Placement
GlobeNewswire
·
March 14, 2025
TORONTO, March 14, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has closed a non-brokered private placement offering of 145,000 common shares priced at CAD $1.55 per common …
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement
GlobeNewswire
·
March 14, 2025
DUBLIN, March 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice today from the Nasdaq …
Pacira BioSciences Confirms Receipt of Director Nominations from DOMA Perpetual
GlobeNewswire
·
March 14, 2025
-- No Shareholder Action Required at This Time -- PARSIPPANY, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of …
Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering
GlobeNewswire
·
March 14, 2025
KIRKLAND, Wash., March 14, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, announced today that the underwriters of Kestra’s initial public offering exercised in full their …
ExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury Recovery
GlobeNewswire
·
March 14, 2025
TORONTO and HAIFA, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that it has successfully completed an important preclinical study towards its …
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
March 14, 2025
SAN FRANCISCO, March 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier …
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance
GlobeNewswire
·
March 14, 2025
MELBOURNE, Fla., March 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. (OTCPK: FITY), formerly Consumer Automotive Finance, Inc. (OTCPK: CAFI), a dynamic leader in the sports supplement, fitness equipment, and health and wellness sectors, is …
Blue Antioxidant: How Prime Biome Restores Skin with 10x Retinol Strength
GlobeNewswire
·
March 14, 2025
ST. PETERSBURG, Fla., March 14, 2025 (GLOBE NEWSWIRE) -- Prime Biome is a holistic daily supplement whose Blue Antioxidant is touted to be up to ten times stronger than standard retinol. For decades, retinol has dominated the anti-aging discussion, …
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
GlobeNewswire
·
March 14, 2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 14 MARCH 2025 at 15.30 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has …
Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)
GlobeNewswire
·
March 14, 2025
ORION OYJ PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE 14.3.2025 KLO 15.30 Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n …
Healthcare Integrated Technologies Inc. Successfully Raises $10 million in Friends & Family Funding
GlobeNewswire
·
March 14, 2025
Knoxville, TN, March 14, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces the successful completion of a $10 million capital raise as part of …
Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments
GlobeNewswire
·
March 14, 2025
Raanana, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today that it has signed a …
Structural Heart Devices Market to Hit US$25.69 Billion by 2029 with 9.5% CAGR | MarketsandMarkets™.
GlobeNewswire
·
March 14, 2025
Delray Beach, FL, March 14, 2025 (GLOBE NEWSWIRE) -- The global structural heart devices market , valued at US$14.93 billion in 2023, is forecasted to grow at a robust CAGR of 9.5%, reaching US$16.31 billion in 2024 and an impressive US$25.69 billion by …
Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to Determine Clonal Tumor Mutation Burden
GlobeNewswire
·
March 14, 2025
Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cells Gradalis applies a novel clinically relevant approach to determine clonal tumor mutation burden/neoantigens, thereby potentially expanding the use …
Hepion Pharmaceuticals Announces Reverse Stock Split
GlobeNewswire
·
March 14, 2025
Shares Expected to Begin Trading on Split-Adjusted Basis on March 18, 2025 MORRISTOWN, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for …